proficiency exam Flashcards
acetaminophen/codeine/ oxycodone PC
analgesic combo (opioid)
albuterol (salbutamol) PC
beta2 agonist
aldendronate sodium PC
biphosphonate derivative
acetaminophen/ codeine/ oxycodone MOA
binds to opiate receptors
acetaminophen/ codeine/ oxycodone use
pain management
acetaminophen/ codeine/ oxycodone admin
shake oral solution/suspension
acetaminophen/ codeine/ oxycodone MP
pain, resp/mental status, BP, HR, s/s substance abuse
albuterol (salbutamol) MOA
relaxes bronchial smooth muscle by action on beta2 receptors
albuterol (salbutamol) use
bronchospasm, asthma // hyperkalemia
albuterol (salbutamol) admin
oral inhalation
albuterol (salbutamol) AE
excitement, nervousness, tremor, bronchospasm, pharyngitis, URI, rhinitis
albuterol (salbutamol) MP
peak flow, BP, HR, glucose, k+, EKG
aldendronate sodium MOA
inhibits bone reabsorption via actions on osteoclasts
aldendronate sodium use
osteoporosis treatment/prevention, paget disease// prostate cancer
aldendronate sodium admin
first thing in the morning with water
aldendronate sodium AE
femur fractures, GI irritation, hypocalemia, osteonecrosis of jaw
aldendronate sodium MP
serial bone mineral density
alprazolam PC
benzodiazepine
alprazolam MOA
binds to stereospecific benzodiazepine receptors on postsynaptic GABA neuron @ several sites within CNS
alprazolam use
anxiety// vertigo
alprazolam admin
controlled IV; oral
alprazolam AE
anterograde amnesia, rash, decreased libido, weight gain/loss, increased/decreased appetite, xerostomia, ataxia, drowsiness, dizziness, depression, fatigue, irritability, sedated
alprazolam MP
resp/cardio status, mental alertness, mis/abuse
amitriptyline PC
tricyclic antidepressant
amitriptyline MOA
increases synaptic concentration of serotonin &/or norepinephrine in CNS by inhibition of their reuptake
amitriptyline use
major DD// cyclic vomiting syndrome, fibromyalgia, h/a, IBS
amitriptyline admin
oral-night/evening
amitriptyline AE
anticholinergic- constipation, xerostomia, blurry vision, urinary retention, CNS depression, bleeding, fractures, hyponatremia, orthostatic hypotension, SI, withdrawal, serotonin syndrome,
amitriptyline MP
mental status, behavior changes, GI symptoms, vital signs
amlodipine PC
calcium channel blocker (CCB)
amlodipine MOA
inhibits calcium ion from entering “slow channels”
amlodipine use
angina, HTN, // raynaud phenomenon
amlodipine admin
oral w/o regards to meals
amlodipine AE
peripheral edema
amlodipine MP
HR, BP, edema
amoxicillin PC
penicillin antibiotic
amoxicillin MOA
inhibits bacterial cell wall synthesis
amoxicillin use
ENT infections, H. pylori, lower resp infection, UTI // endocarditis
amoxicillin admin
oral
amoxicillin AE
diarrhea, C.diff, drug-induced enterocolitis
amoxicillin MP
renal/hepatic/hematological function; signs of sensitivity
amoxicillin/clavulanate PC
penicillin antibiotic
amoxicillin/clavulanate USE
lower resp. infection, otitis media, UTI, diabetic foot
amoxicillin/clavulanate admin
oral with food
amoxicillin/clavulanate MP
renal, hepatic function
atenolol PC
beta-blocker
atenolol MOA
blocks response to beta-adrenergic stimulation, no effect on beta2
atenolol USE
angina, HTN, MI // a fib/flutter, SVT, ventricular arrhythmias
atenolol ADMIN
oral w/o regards to meals
atenolol AE
bradycardia, hypotension, SVT, ventricular tachy, bronchospasm, fatigue, insomnia,
atenolol MP
BP, HR, kidney function, mental alertness, glucose, s/s bronchospasm
atorvastatin PC
HMG-COA reductase inhibitor
atorvastatin MOA
inhibits 3-hydroxy-3-methylglutaryl coenzyme A
atorvastatin USE
hypercholesterolemia, prevention cardiovascular disease// post transplant
atorvastatin ADMIN
oral- suspension before meals, tablet- w/o regards to meals
atorvastatin AE
diarrhea, arthralgia, nasopharyngitis
atorvastatin MP
lipid panel, hepatic levels
azithromycin (systemic) PC
antibiotic, macrolide
azithromycin (systemic) MOA
inhibits RNA-dependent protein synthesis
azithromycin (systemic) USE
genital ulcer disease, acute COPD, otitis media, pelvic inflammatory disease, pneumonia, rhinosinusitis, skin, urethritis/cervicitis
azithromycin (systemic) ADMIN
IV/oral
azithromycin (systemic) AE
diarrhea, nausea, ototoxicity, C dif
azithromycin (systemic) MP
CBC w/dif, EKG
Cephalexin MOA
inhibits cell wall synthesis
Cephalexin PC
cephalosporin anitbiotic
Cephalexin USE
bone infections. otitis media, respiratory tract infections, skin, soft tissue, UTI//endocarditis, prosthetic joint
Cephalexin ADMIN
oral
Cephalexin AE
C.dif, hemolytic anemia,
Cephalexin MP
renal, hepatic, hematologic function
cetirizine (systemic) PC
histamine H1 antagonist
cetirizine (systemic) MOA
competes w/histamine for H1-receptor sites on effector cells
cetirizine (systemic) USE
allergic rhinitis, urticaria// anaphylaxis, angioedema,
cetirizine (systemic) ADMIN
oral, IV over 1-2 mins
cetirizine (systemic) AE
drowsiness, fatigue, psychosis, delusion, h/a
cetirizine (systemic) MP
relief of symptoms, mental alertness
clonazepam PC
benzodiazepine
clonazepam MOA
enhance activity of GABA
clonazepam USE
panic disorders, seizures disorders// anxiety, agitation, TD, verigo
clonazepam ADMIN
C-IV, oral
clonazepam AE
ataxia, behavioral problems, dizziness, drowsiness, CNS effects, anterograde amnesia
clonazepam MP
mental alertness, CBC, liver/renal tests, suicidality
clopidogrel (plavix) PC
antiplatelet, thienopyridine
clopidogrel (plavix) MOA
blocks P2Y12 component of ADP receptors
clopidogrel (plavix) USE
acute coronary syndrome, ST-elevation (&non), MI, stroke//carotid artery
clopidogrel (plavix) ADMIN
oral w/o regards to food
clopidogrel (plavix) AE
bleeding